To cite this paper use one of the standards below:
Fragment screening has emerged as an important tool in the pipeline of drug discovery. By using compounds of low molecular weight, it is possible to cover a broader range of the chemical space with fewer compounds. This project focuses on the use of the fragment-based lead discovery technique to search for novel chemical entities as precursors of selective and potent inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase (SmDHODH) with drug-like properties. Schistosoma mansoni is among the five species responsible for the schistosomiasis. DHODH is a flavoenzyme that catalyzes the stereospecific oxidation of (S)-dihydroorotate (DHO) to orotate, the selective inhibition of DHODH has been exploited for the development of innovative therapeutic strategies. We have recently developed a reproducible crystallization condition, which will be used to map the structural basis of interaction between SmDHODH and selective inhibitors. Fragment screening against different libraries allowed us to identify SmDHODH inhibitor in the nanomolar range.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper